• Welcome, Guest. Please login or register.
    December 12, 2019, 01:30:28 PM

  • Login with username, password and session length

Sajid's dove

Tell everyone they can now find this site by typing this into their browser:

thalpal.com

Click to visit us on Facebook


If you have any problems registering or signing in, please send an email to: andythalpal@yahoo.com
Please do not send questions about thalassemia to this address.


Administrators
Andy
Danielle

Thalassemia Patients and Friends and thalpal © A. Battaglia 2019





55167 Posts in 5879 Topics by 6158 Members
Latest Member: mohamohy

Forum Tip: 
Put your birthdate in your profile, under "Forum Profile Information," and it will automatically come up on our calendar.
« previous next »
Pages: « 1 2 3 4 5 6 7 8 9 10 11 12 13 » Go Down Print
Author Topic: Bluebird Bio Releases Data on Current Gene Therapy Trials  (Read 100897 times)
Sharmin
Global Moderator
Supreme Member
*****
Offline Offline

Location: Canada

Gender: Female
Posts: 4155


Little A


« Reply #30 on: December 05, 2014, 12:51:42 AM »

I am hopeful that the news will be good.  I am also worried about Sloan Kettering.  I had really been hoping that their myelosuppression method would be more successful.


I wonder if the greater success bluebird is enjoying is due to the myeloablation or if they are using a superior method of gene transfer?
Logged

Sharmin
JV
Junior Member
***
Offline Offline

Posts: 102


« Reply #31 on: December 05, 2014, 06:33:05 AM »

Andy, could you elaborate on Sloan a little more because I feel the same way. Delays, not much news, poor results, etc...
Logged
Canadian_Family
Supreme Member
*****
Offline Offline

Posts: 1064



« Reply #32 on: December 05, 2014, 12:02:33 PM »

You are right on Andy. Yes, when a stock reaches 42-43, insiders seems to be dumping the stock. Now the question is if external analyst have a target price of stock at 50-57, why would one just dump the stock at 42-43. Please see few examples, there are number of other examples.

CEO Nick Leschly sold 25,000 shares of bluebird bio stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $41.68, for a total transaction of $1,042,000.00

bluebird bio (NASDAQ:BLUE) Insider Mitchell H. Finer sold 18,000 shares of bluebird bio stock on the open market in a transaction dated Monday, December 1st. The stock was sold at an average price of $39.70, for a total value of $714,600.00....

Lets see what happens at ASH presentation.
Logged

Regards.
Andy Battaglia
Administrator
Supreme Member
*****
Offline Offline

Location: In my heart, Maldives

Gender: Male
Posts: 8608


Will thal rule you or will you rule thal?


« Reply #33 on: December 05, 2014, 01:11:45 PM »

The timing is interesting, but I don't want to read anything into it until we hear what is released at ASH.

JV, all I know is what Pat G said and it sounded like they are not currently beginning new patients in trials. My concern is the money side and what may be attempts to stifle the competition. I have very little faith in the top management at SK. I think they can be bought.
Logged

Andy

All we are saying is give thals a chance.
JV
Junior Member
***
Offline Offline

Posts: 102


« Reply #34 on: December 07, 2014, 10:20:27 AM »

Thanks Andy, ya I agree with you. I wonder how much of Cooleys Funding goes into that research...
Logged
Sharmin
Global Moderator
Supreme Member
*****
Offline Offline

Location: Canada

Gender: Female
Posts: 4155


Little A


« Reply #35 on: December 07, 2014, 02:28:22 PM »

That is all very concerning.  Things are not moving at SK at all.  Most of our cards are on BB at this time.  With the momentum these two groups started off last year - it is very surprising that more exciting news is not coming out and there is no sign of new patients being treated by either group.  

The last BB update in November stated that the first two patients continue to be transfusion free, expressing high rates of the new hemoglobin.  

Praying for the best news from both of these groups.  

Very disappointing that what is a life line for some of us - is a money making scheme for some
« Last Edit: December 07, 2014, 07:22:10 PM by Sharmin » Logged

Sharmin
JV
Junior Member
***
Offline Offline

Posts: 102


« Reply #36 on: December 07, 2014, 07:12:08 PM »

Sharmin, that was very well put. We have been all in since day one and for a major organization like SK to not be more proactive is extremely disappointing. Hoping for Bluebird to run with it now...
Logged
Bostonian_04
Senior Member
****
Offline Offline

Location: Boston

Gender: Male
Posts: 392


« Reply #37 on: December 08, 2014, 07:17:51 PM »

Latest from Bluebird....

Bluebird posts more promising results for its rare disease therapy
December 8, 2014

http://www.fiercebiotech.com/press-releases/bluebird-bio-announces-data-demonstrating-first-four-patients-thalassemia-m
Logged

Quis custodiet ipsos custodes ? - Plato
Andy Battaglia
Administrator
Supreme Member
*****
Offline Offline

Location: In my heart, Maldives

Gender: Male
Posts: 8608


Will thal rule you or will you rule thal?


« Reply #38 on: December 08, 2014, 08:22:21 PM »

These results include the first that Bluebird has done using thalassemia major patients. The early results are quite impressive. We will be eagerly waiting for the results on the one sickle cell patient that has started.

It is still quite early on, and hopefully there will be no serious issues develop down the road, but we now know with certainty that gene therapy does work. I will not hesitate to tell patients to take part in trials if eligible. It may be the only way many patients will ever be able to afford it.
Logged

Andy

All we are saying is give thals a chance.
Sharmin
Global Moderator
Supreme Member
*****
Offline Offline

Location: Canada

Gender: Female
Posts: 4155


Little A


« Reply #39 on: December 08, 2014, 08:45:36 PM »

Bostonian,

Thank you soooo much for posting this!  Such great news!  Praying that it provides a solution for everyone suffering from thalassemia or sickle cell anemia!

Sharmin
Logged

Sharmin
Andy Battaglia
Administrator
Supreme Member
*****
Offline Offline

Location: In my heart, Maldives

Gender: Male
Posts: 8608


Will thal rule you or will you rule thal?


« Reply #40 on: December 08, 2014, 09:01:34 PM »

And for those keeping track, Bluebird's stock rose more than $4/share today.
Logged

Andy

All we are saying is give thals a chance.
Parin
Junior Member
***
Offline Offline

Location: USA

Gender: Male
Posts: 136


« Reply #41 on: December 08, 2014, 11:48:58 PM »

Bluebird Bio Announces Data Demonstrating First Four Patients with β-Thalassemia Major Treated with LentiGlobin™ are Transfusion-Free

http://investor.bluebirdbio.com/phoenix.zhtml?c=251820&p=irol-newsArticle&ID=1995913


Regards,
Ashutosh
Logged
Sharmin
Global Moderator
Supreme Member
*****
Offline Offline

Location: Canada

Gender: Female
Posts: 4155


Little A


« Reply #42 on: December 09, 2014, 11:31:37 AM »

This news is beyond incredible Andy.  For Beta zero patients - I am assuming we would be looking at patient 1106 and 1107 for the next few months.  It is impressive that their hemoglobins are 9.6 are 3 months and 1 month.   Even if the hemoglobin were to stay at this level it is remarkable success. 

Hoping this works for everyone!

It would be nice to see follow up data regarding any possible deficits due to bisulfan - such as fertility.  But that is a future consideration.  for the time being - this is life changing!

Sharmin
Logged

Sharmin
Andy Battaglia
Administrator
Supreme Member
*****
Offline Offline

Location: In my heart, Maldives

Gender: Male
Posts: 8608


Will thal rule you or will you rule thal?


« Reply #43 on: December 09, 2014, 12:10:07 PM »

Bluebird's stock value has doubled today.
Logged

Andy

All we are saying is give thals a chance.
Andy Battaglia
Administrator
Supreme Member
*****
Offline Offline

Location: In my heart, Maldives

Gender: Male
Posts: 8608


Will thal rule you or will you rule thal?


« Reply #44 on: December 09, 2014, 12:35:46 PM »

I should be having another phone conference with Bluebird later this week. If there are any questions you would like asked, please reply by Thursday morning at the latest.
Logged

Andy

All we are saying is give thals a chance.
Pages: « 1 2 3 4 5 6 7 8 9 10 11 12 13 » Go Up Print 
« previous next »
Jump to:  

Powered by MySQL Powered by PHP Powered by SMF 1.1.21 | SMF © 2015, Simple Machines Valid XHTML 1.0! Valid CSS!